Financial Ratios

BERYL DRUGS LTD.

NSE : NABSE : 524606ISIN CODE : INE415H01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE29.33-0.29 (-0.98 %)
PREV CLOSE ( ) 29.62
OPEN PRICE ( ) 31.09
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4446
TODAY'S LOW / HIGH ( )28.60 31.10
52 WK LOW / HIGH ( ) 11.6544.98
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.51-1.300.470.091.16
   CEPS(Rs)3.120.842.981.391.80
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)15.8614.3415.5914.9914.80
   Tax Rate(%)22.1530.6531.1569.6425.81
Margin Ratios
   Core EBITDA Margin(%)7.392.9510.287.077.89
   EBIT Margin(%)5.39-3.365.773.747.27
   Pre Tax Margin(%)3.66-6.512.471.236.14
   PAT Margin (%)2.85-4.511.700.374.56
   Cash Profit Margin (%)5.882.9310.745.527.06
Performance Ratios
   ROA(%)4.36-3.631.350.314.67
   ROE(%)10.00-8.683.090.638.35
   ROCE(%)11.51-3.826.284.059.96
   Asset Turnover(x)1.530.800.790.821.02
   Sales/Fixed Asset(x)2.671.481.412.074.98
   Working Capital/Sales(x)6.747.337.2714.46-96.05
Efficiency Ratios
   Fixed Capital/Sales(x)0.370.680.710.480.20
   Receivable days77.03112.34103.5398.14116.36
   Inventory Days27.3765.5744.3727.3629.73
   Payable days735.121616.731005.85754.83410.30
Valuation Parameters
   PER(x)8.050.0013.9938.617.18
   PCE(x)3.9012.402.222.624.63
   Price/Book(x)0.770.730.420.240.56
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.380.680.570.520.57
   EV/Core EBITDA(x)4.4716.644.915.885.83
   EV/EBIT(x)6.99-20.249.8613.967.84
   EV/CE(x)0.580.560.430.400.51
   M Cap / Sales0.230.360.240.140.33
Growth Ratio
   Net Sales Growth(%)84.123.629.97-1.12-14.42
   Core EBITDA Growth(%)279.76-63.5343.63-10.10-27.02
   EBIT Growth(%)395.96-160.2269.85-49.16-32.96
   PAT Growth(%)216.24-375.04399.78-91.88-40.51
   EPS Growth(%)216.23-375.04399.78-91.88-40.50
Financial Stability Ratios
   Total Debt/Equity(x)0.560.730.650.690.43
   Current Ratio(x)1.621.231.241.130.98
   Quick Ratio(x)1.460.880.960.960.84
   Interest Cover(x)3.11-1.061.751.496.45
   Total Debt/Mcap(x)0.741.001.532.830.77

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.